BRUKER CORP (BRKR) Stock Fundamental Analysis
NASDAQ:BRKR - Nasdaq - US1167941087 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 55 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
In the past year BRKR had a positive cash flow from operations.
Each year in the past 5 years BRKR has been profitable.
In the past 5 years BRKR always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.95%, BRKR is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
BRKR has a better Return On Equity (6.35%) than 74.55% of its industry peers.
BRKR has a better Return On Invested Capital (5.74%) than 69.09% of its industry peers.
BRKR had an Average Return On Invested Capital over the past 3 years of 9.30%. This is below the industry average of 12.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.95% | ||
| ROE | 6.35% | ||
| ROIC | 5.74% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR has a better Profit Margin (3.36%) than 69.09% of its industry peers.
In the last couple of years the Profit Margin of BRKR has declined.
BRKR has a Operating Margin of 11.50%. This is in the better half of the industry: BRKR outperforms 69.09% of its industry peers.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR has a Gross Margin of 49.34%. This is comparable to the rest of the industry: BRKR outperforms 50.91% of its industry peers.
BRKR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.5% | ||
| PM (TTM) | 3.36% | ||
| GM | 49.34% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.36 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of BRKR (2.36) is comparable to the rest of the industry.
BRKR has a debt to FCF ratio of 15.40. This is a negative value and a sign of low solvency as BRKR would need 15.40 years to pay back of all of its debts.
BRKR's Debt to FCF ratio of 15.40 is in line compared to the rest of the industry. BRKR outperforms 58.18% of its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that BRKR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.16, BRKR is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 15.4 | ||
| Altman-Z | 2.36 |
ROIC/WACC0.6
WACC9.5%
2.3 Liquidity
BRKR has a Current Ratio of 1.60. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.60, BRKR is doing worse than 70.91% of the companies in the same industry.
A Quick Ratio of 0.75 indicates that BRKR may have some problems paying its short term obligations.
The Quick ratio of BRKR (0.75) is worse than 89.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.6 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
The earnings per share for BRKR have decreased strongly by -10.07% in the last year.
Measured over the past years, BRKR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
BRKR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.56%.
BRKR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-10.07%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-5%
Revenue 1Y (TTM)13.56%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%14.64%
3.2 Future
Based on estimates for the next years, BRKR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.14% on average per year.
The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y10.74%
EPS Next 2Y13.11%
EPS Next 3Y13.62%
EPS Next 5Y13.14%
Revenue Next Year3.98%
Revenue Next 2Y4.98%
Revenue Next 3Y5.42%
Revenue Next 5Y5.38%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.57 indicates a correct valuation of BRKR.
Compared to the rest of the industry, the Price/Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 89.09% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, BRKR is valued a bit cheaper.
A Price/Forward Earnings ratio of 13.16 indicates a correct valuation of BRKR.
BRKR's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 90.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, BRKR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.57 | ||
| Fwd PE | 13.16 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 87.27% of the companies listed in the same industry.
BRKR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BRKR is cheaper than 67.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.12 | ||
| EV/EBITDA | 12.98 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BRKR's earnings are expected to grow with 13.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)1.63
EPS Next 2Y13.11%
EPS Next 3Y13.62%
5. Dividend
5.1 Amount
BRKR has a yearly dividend return of 0.55%, which is pretty low.
The stock price of BRKR dropped by -36.22% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.54. BRKR pays more dividend than 92.73% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.51, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has paid a dividend for at least 10 years, which is a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years7
5.3 Sustainability
BRKR pays out 26.70% of its income as dividend. This is a sustainable payout ratio.
The dividend of BRKR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.7%
EPS Next 2Y13.11%
EPS Next 3Y13.62%
NASDAQ:BRKR (4/21/2025, 11:48:09 AM)
35.11
-1.17 (-3.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.93%
Inst Owner Change-0.34%
Ins Owners26.92%
Ins Owner Change0.3%
Market Cap5.32B
Analysts80
Price Target67.59 (92.51%)
Short Float %5.53%
Short Ratio3.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP26.7%
Div Incr Years0
Div Non Decr Years7
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.13%
Min EPS beat(2)-0.9%
Max EPS beat(2)1.16%
EPS beat(4)2
Avg EPS beat(4)2.43%
Min EPS beat(4)-2.58%
Max EPS beat(4)12.06%
EPS beat(8)6
Avg EPS beat(8)6.88%
EPS beat(12)9
Avg EPS beat(12)7.2%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-1%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)-0.62%
Revenue beat(8)4
Avg Revenue beat(8)0.92%
Revenue beat(12)7
Avg Revenue beat(12)1%
Revenue beat(16)11
Avg Revenue beat(16)1.66%
PT rev (1m)-0.58%
PT rev (3m)-8.46%
EPS NQ rev (1m)1.84%
EPS NQ rev (3m)-18.65%
EPS NY rev (1m)-1.78%
EPS NY rev (3m)-3.06%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-7.52%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-3.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.57 | ||
| Fwd PE | 13.16 | ||
| P/S | 1.58 | ||
| P/FCF | 39.12 | ||
| P/OCF | 21.17 | ||
| P/B | 2.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.98 |
EPS(TTM)2.41
EY6.86%
EPS(NY)2.67
Fwd EY7.6%
FCF(TTM)0.9
FCFY2.56%
OCF(TTM)1.66
OCFY4.72%
SpS22.22
BVpS11.76
TBVpS-4.21
PEG (NY)1.36
PEG (5Y)1.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.95% | ||
| ROE | 6.35% | ||
| ROCE | 8.55% | ||
| ROIC | 5.74% | ||
| ROICexc | 5.98% | ||
| ROICexgc | 13.51% | ||
| OM | 11.5% | ||
| PM (TTM) | 3.36% | ||
| GM | 49.34% | ||
| FCFM | 4.04% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score3
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 15.4 | ||
| Debt/EBITDA | 3.61 | ||
| Cap/Depr | 62.73% | ||
| Cap/Sales | 3.43% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 44.03% | ||
| Profit Quality | 120.25% | ||
| Current Ratio | 1.6 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | 2.36 |
F-Score3
WACC9.5%
ROIC/WACC0.6
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.07%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-5%
EPS Next Y10.74%
EPS Next 2Y13.11%
EPS Next 3Y13.62%
EPS Next 5Y13.14%
Revenue 1Y (TTM)13.56%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%14.64%
Revenue Next Year3.98%
Revenue Next 2Y4.98%
Revenue Next 3Y5.42%
Revenue Next 5Y5.38%
EBIT growth 1Y-20.48%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year36.69%
EBIT Next 3Y19.2%
EBIT Next 5Y17.94%
FCF growth 1Y-44.08%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-28.22%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%